IMRX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious HOV Q1 2026 Earnings Surprise EPS Beat Amid Challenging Housing Market MMM Q1 2026 Earnings Earnings Beat Estimates on Cost Discipline and Operational Efficiency